Abstract
Ly-5 (CD45) glycoproteins of the mouse, expressed by all or most hematopoietic cell lineages and specified by a single Ly-5 gene, range in size from isoform T200 of T cells (the smallest), in which exons 4, 5, and 6 are not represented, to isoform B220 of B cells (the largest), in which all three of these optional exons are represented. The main purpose of the present study, utilizing the polymerase chain reaction (PCR), was to ascertain whether known isoforms of intermediate size are generated by single or dual usage of optional exons 4, 5, and 6. Transcripts representing all eight isoforms predictable from varied use of three exons were observed among a diverse panel of nine B-cell tumors in culture, but there was no evident concordance with known contrasting differential features that distinguish members of the B-cell tumor panel. No two B tumors exhibited the same variety of transcripts and the relative quantities of transcripts expressed varied greatly from tumor to tumor. Cloning of B-cell tumors did not alter their distinctive transcript patterns. Separation methods (sodium dodecyl sulfate polyacrylamide gel electrophoresis; SDS-PAGE) did not suffice to segregate all corresponding expressed isoforms but did establish that transcripts representing usage of a single optional exon and of two optional exons were actually translated, which supports a provisional inference that all eight isoforms exist. The considerable diversity of B-cell transcript phenotypes was not seen among seven T-cell leukemias, two cytolytic T-cell lines, and three Th1 helper T-cell lines, all of which displayed a uniform phenotype comprising major expression of the T200 transcript (no optional exon) and minor expression of a transcript employing exon 5. However, a panel of five cloned Th2 T-cell lines, which represents a second and functionality different branch of the helper/inducer T-cell category, exhibited a characteristic transcript pattern which distinguished them from a panel of three Th1 T-cell lines. The major transcript in the Th2 lines was also T200, but the Th2 lines showed higher representation of transcript containing optional exons. A single Th2 clone expressed an unusual transcript suggesting a potential isoform not compounded simply by varied inclusion of the three identified optional exons. After activation of the helper T-cell lines with concanavalin A (Con A), expression of transcript containing optional exons appeared to decrease.
Similar content being viewed by others
References
Akbar, A. N., Terry, L., Timms, A., Beverley, P. C. L., and Janossy, G.: Loss of CD45 and gain of UCHLI reactivity is a feature of primed T cells.J Immunol 140: 2171–2178, 1988
Barclay, A. N., Jackson, D. I., Willis, A. C., and Williams, A. F.: Lymphocyte specific heterogeneity in the rat leucocyte commonantigen (T200) is due to differences in polypeptide sequences near the NH2-terminus.EMBO J 6: 1259–1264, 1987
Birkeland, M. L., Johnson, P., Trowbridge, I. S., and Pure, E.: Changes in CD45 isoform expression accompany antigen-induced routine T-cell activation.Proc Natl Acad Sci USA 86: 6734–6738, 1989
Bottomly, K.: A functional dichotomy in CD4+ T lymphocytes.Immunol Today 9: 268–274, 1988
Bottomly, K., Luqman, M., Greenbaum, L., Carding, S., West, J., Pasqualini, T., and Murphy, D. B.: A monoclonal antibody to routine CD45R distinguishes CD4 T cell populations that produce different cytokines.Ear J Immunol 19: 617–623, 1989
Burns, G. F., Werkmeister, J. A., and Triglia, T.: A novel antigenic cell surface protein associated with T200 is involved in the postactivation stage of human NK cell-mediated lysis.J Immunol 133: 1391–1396, 1984
Chang, H.-L., Zaroukian, M. H., and Esselman, W. J.: T200 alternate exon use in murine lymphoid cells determined by reverse transcription-polymerase chain reaction.J Immunol 143: 315–321, 1989
Charbonneau, H., Tonks, N. K., Walsh, K. A., and Fischer, E. H.: The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase.Proc Natl Acad Sci USA 85: 7182–7186, 1988
Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Analyt Biochem 162: 156–159, 1987
Davidson, W. F., Frederickson, T. N., Rudikoff, E. K., Coffman, R. L., Hartley, J. W., and Morse, H. C., III: A unique series of lymphomas related to the Ly-1+ lineage of B lymphocyte differentiation.J Immunol 133: 744–753, 1984
Deans, J. P., Boyd, A. W., and Pilarski, L. M.: Transitions from high to low molecular weight isoforms of CD45 (T200) involve rapid activation of alternate mRNA splicing and slow turnover of surface CD45R.J Immunol 143: 1233–1238, 1989
Harp, J. A., Davis, B. S., and Ewald, S. J.: Inhibition of T cell responses to alloantigens and polyclonal mitogens by Ly-5 antisera.J Immunol 133: 10–15, 1984
Johnson, P., Greenbaum, L., Bottomly, K., and Trowbridge, I. S.: Identification of the alternatively spliced exons of murine CD45 (T200) required for reactivity with B220 and other T200-restricted antibodies.J Exp Med 169: 1179–1184, 1989
Kiener, P. A. and Mittler, R. S.: CD45-protein tyrosine phosphatase cross-linking inhibits T cell receptor CD3-mediated activation in human T cells.J Immunol 143: 23–28, 1989
Kurt-Jones, E. A., Hamberg, S., Ohara, J., Paul, W. E., and Abbas, A. K.: Heterogeneity of helper inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness.J Exp Med 166: 1774–1787, 1987
Laemmli, V.: Cleavage of structural protein during the assembly of the head of bacteriophage T4.Nature 227: 680–685, 1970
Ledbetter, J. A., Tonks, N. K., Fischer, E. H., and Clark, E. A.: CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.Proc Natl Acad Sci USA 85: 8628–8632, 1988
Lefrancois, L. and Bevan, M. J.: Functional modifications of cytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies.Nature 314: 449–452, 1985
Maniatis, T., Fritsch, E. F., and Sambrook, J.:Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, 1982
Morishima, Y., Ogata, S., Collins, N. H., Dupont, B., and Lloyd, K. O.: Carbohydrate differences in human high molecular weight antigens of B- and T-cell lines.Immunogenetics 15: 529–535, 1982
Mosmann, T. M. and Coffman, R. L.: Two types of mouse helper T-cell clones: implication for immune regulation.Immunol Today 8: 223–227, 1987
Newman, W.: Selective blockade of human natural killer cells by a monoclonal antibody.Proc Natl Acad Sci USA 79: 3858–3862, 1982
Ralph, S. J., Thomas, M. L., Morton, C. C., and Trowbridge, I. S.: Structural variants of human T200 glycoprotein (leukocyte-common antigen).EMBO J 6: 1251–1257, 1987
Saga, Y., Tung, J. S., Shen, F.-W., and Boyse, E. A.: Sequences of Ly-5 cDNA: isoform-related diversity of Ly-5 mRNA.Proc Natl Acad Sci USA 83: 6940–6944, 1986
Saga, Y., Tung, J. S., Shen, F.-W., and Boyse, E. A.: Alternative use of 5′ exons in the specification of Ly-5 isoforms distinguishing hematopoietic cell lineages.Proc Natl Acad Sci USA 84: 5364–5368, 1987
Saga, Y., Tung, J. S., Shen, F.-W., Pancoast, T. C., and Boyse, E. A.: Organization of the Ly-5 gene.Mol Cell Biol 8: 4889–4895, 1988
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Erlich, H. A.: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.Science 239: 487–497, 1988
Scheid, M. P. and Triglia, D.: Further description of the Ly-5 system.Immunogenetics 9: 423–433, 1979
Streuli, M. and Saito, H.: Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNA.EMBO J 8: 787–796, 1989
Streuli, M., Hall, L. R., Saga, Y., Schlossman, S. F., and Saito, H.: Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.J Exp Med 166: 1548–1566, 1987
Streuli, M., Morimoto, C., Schrieber, M., Schlossman, S. F., and Saito, H.: Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens.J Immunol 141: 3910–3914, 1988
Thomas, M. L.: The leukocyte common antigen family.Anna Rev Immunol 7: 339–369, 1989
Thomas, M. L. and Lefrancois, L.: Differential expression of the leukocyte-common antigen family.Immunol Today 9: 320–326, 1988
Thomas, M. L., Reynolds, P. J., Chain, A., Ben-Neriah, Y., and Trowbridge, I. S.: B-cell variant of mouse T200 (Ly-5): evidence for alternative mRNA splicing.Proc Natl Acad Sci USA 84: 5360–5363, 1987
Tonks, N. K., Charbonneau, H., Diltz, C. D., Fischer, E. H., and Walsh, K. A.: Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase.Biochemistry 27: 8695–8701, 1988
Tung, J.-S., Scheid, M. P., Pierotti, M. A., Hämmerling, U., and Boyse, E. A.: Structural features and selective expression of three Ly-5+ cell-surface molecules.Immunogenetics 14: 101–106, 1981
Tung, J. -S., Saga, Y., and Boyse, E. A.: Structural features of Ly-5 glycoproteins of the mouse and counterparts in other mammals.Immunogenetics 28: 271–277, 1988
Yakura, H., Shen, F.-W., Bourcet, E., and Boyse, E. A.: On the function of Ly-5 in the regulation of antigen-driven B cell differentiation: comparison and contrast with Lyb-2.J Exp Med 157: 1077–1088, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saga, Y., Furukawa, K., Rogers, P. et al. Further data on the selective expression of Ly-5 isoforms. Immunogenetics 31, 296–306 (1990). https://doi.org/10.1007/BF02115003
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02115003